Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Coronary Artery Disease V: Surgical Management
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis III: Management
Acute Coronary Syndrome IV: Interprofessional Care
您也可能阅读
通过共同作者、期刊和引用图与本文相关的文章。
Updated: Jun 11, 2025

Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
Bianca Rocca1,2, Elisabetta Bigagli3, Elisabetta Cerbai4
1Department of Safety and Bioethics, Catholic University, Largo F. Vito 1, Rome, Italy.
提卡格雷勒可以抑制乳腺癌抵抗蛋白 (BCRP),增加他类药物水平和狂犬病溶解的风险. 治疗提卡格勒勒和他类药物的心血管患者需要对这种药物相互作用进行仔细监测.
科学领域:
背景情况:
研究的目的:
主要方法:
主要成果:
结论: